Literature DB >> 20959516

Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor.

Thi Ai Diep1, Andreas Nygaard Madsen, Birgitte Holst, Martin Mørch Kristiansen, Niels Wellner, Steen Honoré Hansen, Harald Severin Hansen.   

Abstract

This study was undertaken to investigate the link between dietary fat content and intestinal levels of anorectic N-acylethanolamines (NAEs), including oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and linoleoylethanolamide (LEA). Male rats were fed high-fat diets (HFDs) with variable percentages of fat [20-45% of total energy (E%)] for 1-7 d; afterward, the jejunums were isolated, and jejunal NAE levels were measured by liquid-chromatography mass spectrometry. Enzyme activities and mRNA expression levels were measured for two synthesizing enzymes, N-acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD) and glycerophosphodiesterase (GDE1), and one degrading enzyme, fatty acid amide hydrolase (FAAH). We found a dose-response relation between the quantity/percentage of dietary fat, irrespective of the energy density, and the reduction of intestinal levels of OEA, PEA, and LEA. The reductions were present after 1 d of 45E% HFD. LEA, the major NAE species, was shown to have an anorectic potency slightly less than that of OEA but higher than PEA. Regulation at the enzyme level seems not to explain the changes in NAE levels. The results suggest the presence of a fat sensor, mediating the reduced intestinal NAE levels. The intestinal NAE levels are reduced in a dose- and time-dependent manner in response to dietary fat intake, and this may contribute to the well-known hyperphagic effect of HFDs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959516     DOI: 10.1096/fj.10-166595

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  43 in total

1.  Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice.

Authors:  Clémentine Thabuis; Frédéric Destaillats; Didier M Lambert; Giulio G Muccioli; Matthieu Maillot; Touafiq Harach; Delphine Tissot-Favre; Jean-Charles Martin
Journal:  J Lipid Res       Date:  2011-04-24       Impact factor: 5.922

2.  Modulation of plasma N-acylethanolamine levels and physiological parameters by dietary fatty acid composition in humans.

Authors:  Peter J H Jones; Lin Lin; Leah G Gillingham; Haifeng Yang; Jaclyn M Omar
Journal:  J Lipid Res       Date:  2014-09-28       Impact factor: 5.922

Review 3.  Fat sensing and metabolic syndrome.

Authors:  Jang H Youn
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

4.  Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2-monoacylglycerol.

Authors:  Karen Kleberg; Anne Katrine Jacobsen; Jozelia G Ferreira; Johanne Agerlin Windeløv; Jens F Rehfeld; Jens Juul Holst; Ivan E de Araujo; Harald S Hansen
Journal:  J Physiol       Date:  2015-02-09       Impact factor: 5.182

5.  Symmetrically substituted dichlorophenes inhibit N-acyl-phosphatidylethanolamine phospholipase D.

Authors:  Geetika Aggarwal; Jonah E Zarrow; Zahra Mashhadi; C Robb Flynn; Paige Vinson; C David Weaver; Sean S Davies
Journal:  J Biol Chem       Date:  2020-04-13       Impact factor: 5.157

6.  Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome.

Authors:  Miki Igarashi; Vidya Narayanaswami; Virginia Kimonis; Pietro M Galassetti; Fariba Oveisi; Kwang-Mook Jung; Daniele Piomelli
Journal:  Pharmacol Res       Date:  2016-12-19       Impact factor: 7.658

7.  Two-week administration of engineered Escherichia coli establishes persistent resistance to diet-induced obesity even without antibiotic pre-treatment.

Authors:  Noura S Dosoky; Zhongyi Chen; Yan Guo; Clara McMillan; C Robb Flynn; Sean S Davies
Journal:  Appl Microbiol Biotechnol       Date:  2019-06-15       Impact factor: 4.813

8.  Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D.

Authors:  Zhongyi Chen; Yongqin Zhang; Lilu Guo; Noura Dosoky; Lorenzo de Ferra; Scott Peters; Kevin D Niswender; Sean S Davies
Journal:  J Lipid Res       Date:  2017-06-08       Impact factor: 5.922

9.  Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.

Authors:  Raffaele Capasso; Pierangelo Orlando; Ester Pagano; Teresa Aveta; Lorena Buono; Francesca Borrelli; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 10.  Intestinal lipid-derived signals that sense dietary fat.

Authors:  Nicholas V DiPatrizio; Daniele Piomelli
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.